16 November 202313 November 2023 DMC opens new lab in Research Triangle Park, NC – New 9,500 Square Foot R&D Facility The facility is home to DMC’s workflows in strain and metabolic engineering, high throughput testing, as well as bench and pilot scale fermentation
3 April 202330 March 2023 The 50 Hottest Companies in the Bioeconomy 2023 The Digest slideshow of the top 50 bioeconomy companies
2 November 202231 October 2022 An interview with Kelly Smith, VP R&D DMC Biotech “The crises, while tragic, created an opportunity to rethink security of supply in terms of where things are manufactured, and DMC is positioned to lead the change.” Kelly Smith, VP R&D at DMC Biotech talks with Il Bioeconomista
14 February 202211 February 2022 DMC: Subsequent Close of Series B Financing, Total Raised $39 million DMC is commercial with its first bio-based chemical intermediate with primary applications in sustainable detergents and human nutrition
Start-up für biobasierte Chemikalien gewinnt weitere strategische Investoren Nachträglicher Abschluss der Serie-B-Finanzierung mit einem Gesamtbetrag von 39 Millionen Dollar
9 December 20216 December 2021 DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) Company has a deep pipeline of predictable, scalable, cost-competitive products, addressing sustainability challenges across a wide range of industries
28 May 202116 June 2021 DMC’s Downstream Processing Proven At Scale The purification of L-alanine from the fermentation broth was successfully completed for more than 6,000 kg of product
4 May 202118 June 2021 DMC and Conagen Partner for Commercial Manufacturing of L-alanine Partnership combines Conagen’s production expertise with DMC's bioprocess technology and follows DMC’s demonstration of commercial-scale production in March 2021
21 April 202118 June 2021 DMC & SCG Execute Agreement for DMC’s Amino Acid Product Line in ASEAN "We are excited by the opportunity to bring these biobased, sustainable solutions to the region and to contribute to a more sustainable society"
6 April 202118 June 2021 DMC CTO & Co-Founder Mike Lynch Publishes Technoeconomic Analysis (TEA) Calculator to Take the Guesswork Out of Bioprocess Development The Bioprocess Technoeconomic Analysis (TEA) tool will help users – academics, startups, funding agencies, R&D team, and investors – make commercially relevant decisions about technology development and deployment
19 March 202117 March 2021 DMC Demonstrates Full Commercial Scale at Record Speed The commercial performance metrics were demonstrated, meaning that no further strain improvements are required to achieve the target selling price
17 March 202115 March 2021 Celebrating women CEOs in the renewable chemicals market Here is a list of women CEOs blazing trails in the (renewable) chemicals market
9 December 20207 December 2020 The 10 Most Innovative Bioeconomy CEOs in 2020. Now choose the number 1 Now you can choose the most innovative CEO responding to the Il Bioeconomista survey
3 December 20202 December 2020 An interview with Matt Lipscomb, CEO DMC Bio Exclusive interview with Matt Lipscomb, CEO of DMC Bio, the US company which is producing bio-based chemicals using fermentation
12 February 20209 February 2020 DMC Biotech Completes Successful Pilot of L-alanine The predictability of the DMC process has been demonstrated from high through put screening to commercially relevant scale
6 June 20193 June 2019 Meet the green startup shaking up the chemicals industry DMC Biotechnologies, a US biotechnology company, makes bio-based products using enhanced microbial fermentation